Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.68 |
| ▸ | TSHR | P16473 | 9/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863839 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL9860990 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| Di(Hydroxyethyl)Ether SCHEMBL18317889 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL629901 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL2809295 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| Tetraethylene Glycol SCHEMBL8659912 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL33376 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL2367411 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL864145 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL61385 | 1.00 | THRB (0.68) | THRBTSHRMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210244519-A1 | PHOTOCURABLE COMPOSITION, DENTURE RELINE MATERIAL, AND KIT FOR PREPARING THESE | TOKUYAMA DENTAL CORPORATION (JP) | 2021-08-12 | — | — | US | disclosed |
| EP-3854820-A1 | PHOTOCURABLE COMPOSITION, DENTAL PLATE LINER, AND KIT FOR PREPARING THESE | Tokuyama Dental Corporation (JP) | 2021-07-28 | — | — | EP | disclosed |
| US-10973740-B2 | Powder-liquid type denture base lining material | TOKUYAMA DENTAL CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| EP-3488842-B1 | POWDER-LIQUID TYPE DENTAL PLATE LINER | TOKUYAMA DENTAL CORP (JP) | 2021-03-24 | — | — | EP | disclosed |
| US-20190216689-A1 | POWDER-LIQUID TYPE DENTURE BASE LINING MATERIAL | TOKUYAMA DENTAL CORPORATION (JP) | 2019-07-18 | — | — | US | disclosed |
| EP-3488842-A1 | POWDER-LIQUID TYPE DENTAL PLATE LINER | Tokuyama Dental Corporation (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-20100240840-A1 | Resin Composition and multilayer optical member using the same | HITACHI CHEMICAL CO., LTD. (JP) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10973740-B2 | Powder-liquid type denture base lining material | TAS2R8, TAS2R1, AOC1 | THRB 4089/4885TSHR 2849/4885MEN1 4590/4885 |
| US-20190216689-A1 | POWDER-LIQUID TYPE DENTURE BASE LINING MATERIAL | TAS2R8, TAS2R1, AOC1 | THRB 4089/4885TSHR 2849/4885MEN1 4590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.